235 related articles for article (PubMed ID: 10908092)
1. Adrenergic overload and apoptosis in heart failure: implications for therapy.
Colucci WS; Sawyer DB; Singh K; Communal C
J Card Fail; 2000 Jun; 6(2 Suppl 1):1-7. PubMed ID: 10908092
[TBL] [Abstract][Full Text] [Related]
2. The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.
Communal C; Colucci WS
Arch Mal Coeur Vaiss; 2005 Mar; 98(3):236-41. PubMed ID: 15816327
[TBL] [Abstract][Full Text] [Related]
3. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
4. [Effect of beta3-adrenoreceptors agonist on beta3-adrenoreceptors expression and myocyte apoptosis in a rat model of heart failure].
Kong YH; Li WM; Tian Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):142-7. PubMed ID: 15009959
[TBL] [Abstract][Full Text] [Related]
5. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
[TBL] [Abstract][Full Text] [Related]
6. The cellular and physiologic effects of beta blockers in heart failure.
Sabbah HN
Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
[TBL] [Abstract][Full Text] [Related]
7. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
[TBL] [Abstract][Full Text] [Related]
8. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic pathways and left ventricular remodeling.
Dorn GW
J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
[TBL] [Abstract][Full Text] [Related]
10. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure.
Port JD; Bristow MR
J Mol Cell Cardiol; 2001 May; 33(5):887-905. PubMed ID: 11343413
[TBL] [Abstract][Full Text] [Related]
11. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice.
Bisognano JD; Weinberger HD; Bohlmeyer TJ; Pende A; Raynolds MV; Sastravaha A; Roden R; Asano K; Blaxall BC; Wu SC; Communal C; Singh K; Colucci W; Bristow MR; Port DJ
J Mol Cell Cardiol; 2000 May; 32(5):817-30. PubMed ID: 10775486
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cardiac L-type calcium current response to beta2-adrenergic stimulation in heart failure.
Zhang ZS; Cheng HJ; Ukai T; Tachibana H; Cheng CP
J Pharmacol Exp Ther; 2001 Jul; 298(1):188-96. PubMed ID: 11408541
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure.
Katori T; Hoover DB; Ardell JL; Helm RH; Belardi DF; Tocchetti CG; Forfia PR; Kass DA; Paolocci N
Circ Res; 2005 Feb; 96(2):234-43. PubMed ID: 15591228
[TBL] [Abstract][Full Text] [Related]
14. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
[TBL] [Abstract][Full Text] [Related]
15. Distinct actions of intermittent and sustained β-adrenoceptor stimulation on cardiac remodeling.
Ma X; Song Y; Chen C; Fu Y; Shen Q; Li Z; Zhang Y
Sci China Life Sci; 2011 Jun; 54(6):493-501. PubMed ID: 21706409
[TBL] [Abstract][Full Text] [Related]
16. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
Khamssi M; Brodde OE
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury.
Li D; Qu Y; Tao L; Liu H; Hu A; Gao F; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ
J Surg Res; 2006 Mar; 131(1):64-72. PubMed ID: 16154595
[TBL] [Abstract][Full Text] [Related]
18. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
19. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
[TBL] [Abstract][Full Text] [Related]
20. beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy.
Xydas S; Kherani AR; Chang JS; Klotz S; Hay I; Mutrie CJ; Moss GW; Gu A; Schulman AR; Gao D; Hu D; Wu EX; Wei C; Oz MC; Wang J
J Pharmacol Exp Ther; 2006 May; 317(2):553-61. PubMed ID: 16421285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
